US Patent 12110312 Integrated continuous manufacturing of therapeutic protein drug substances
Patent 12110312 was granted and assigned to Genzyme on October, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+40 properties)
Article (+242 characters)
US Patent 12110312 Integrated continuous manufacturing of therapeutic protein drug substances
Article
Patent abstract
Provided herein are integrated continuous biomanufacturing processes for producing a therapeutic protein drug substance. Also provided are systems that are capable of continuously producing a therapeutic protein drug substance.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Konstantin Konstantinov0
Rahul Godawat0
Sujit Jain0
Veena Warikoo0
Date of Patent
October 8, 2024
0Patent Application Number
169084010
Date Filed
June 22, 2020
0Patent Citations
0
Patent Primary Examiner
Find more entities like US Patent 12110312 Integrated continuous manufacturing of therapeutic protein drug substances
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
